Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report January – March 2023

NET ASSET VALUE AND THE LATOUR SHARE · The net asset value rose to SEK 186 per share, compared with SEK 159 per share at the start of the year. This is an increase of 17.2 per cent. By comparison, the Stockholm Stock Exchange’s Total Return Index (SIXRX) increased by 8.7 per cent. The net asset value was SEK 186 per share at 27 April.[1] · The total return on the Latour share was 6.9 per cent during the period measured against the SIXRX, which rose 8.7 per cent. INDUSTRIAL OPERATIONS · The industrial operations’ order intake rose 8 per cent to SEK 6,320 m (5,840 m). Adjusted

Truecaller AB (publ) publishes Annual Report for 2022

Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, has today published its Annual Report and Sustainability Report for 2022.The report is available for download at corporate.truecaller.com . The Swedish Annual Report is available in European Single Electronic Format (ESEF) on Truecaller's website. For more information, please contact: Andreas Frid, Head of IR & Communication +46 705 29 08 00andreas.frid@truecaller.com This information is

Interim Report 1 January - 31 March 2023

• 53% increase in gross order intake and 56% increase in net sales compared to the corresponding quarter of the previous year• Continued growth in user base globally and continued increase in clinical acceptance• Distribution network established in the US ”In the first quarter of 2023, we experienced our best quarter to date in all respects, with higher sales (+56%), greater gross order intake (+53%) and more customers (+20%). On a rolling 12 months basis, the user base, i.e. the number of orthopaedic surgeons who use Episealer®, increased by 46% (105), and user base growth is of

Notice of Extraordinary General Meeting in Starbreeze AB (publ)

The shareholders of Starbreeze AB (publ), Reg. No. 556551–8932, are given notice of the Extraordinary General Meeting to be held on Wednesday 24 May 2023 at 10.00 in Celsiussalen, Citykonferensen, Malmskillnadsgatan 46, Stockholm, Sweden. Registration for the meeting starts at 09.30.The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the Extraordinary General Meeting also by postal voting in accordance with the regulations in Starbreeze's Articles of Association. Right to participate and notification Participation in the meeting room

Notice of annual general meeting of Calliditas Therapeutics AB (publ)

The shareholders of Calliditas Therapeutics AB (publ) (“Calliditas Therapeutics”), Reg. No. 556659-9766, with registered office in Stockholm, are summoned to the annual general meeting on Tuesday 30 May 2023 at Klara, Klarabergsviadukten 90, Stockholm, Sweden. Registration starts at 10.00 CEST.Right to participate in the annual general meeting and notice of participation Participation in the annual general meeting at the venue A shareholder who wishes to participate in the annual general meeting at the venue in person or represented by a proxy must (i) be recorded as a shareholder in

Heliospectra (publ) Publish the Interim Report for January to March 2023

(GOTHENBURG, Sweden, Apr 28, 2023, at 08:30 CEST)– Heliospectra AB (publ), a leader in intelligent lighting technology for greenhouse and controlled plant growth environments, presents its Interim Report for January to March 2023.Full report is enclosed to this press release and is also uploaded at https://www.heliospectra.com/investor-relations/reports-documents-archive. SUMMARY OF REPORT Sales and financial performance January – March 2023 · Order intake during the period amounted to SEK 1,649 (2,041) thousand. · Net sales during the period amounted to SEK 7,033 (5,562)

#23-35 Trading halt in Meltron AB

NGM has decided to halt the trading in the shares of Meltron AB effective immediately. Trading will be halted until further notice in accordance with Chapter 11, Section 12 of the Securities Market Act. The trade halt is due to non-disclosure of inside information about the issuer or the issuer’s financial instrument pursuant Chapter 22, Section 1, Paragraph 3 of the Securities Market Act.The Financial Supervisory Authority has been notified about the trade halt and has decided that it will remain until further notice in accordance with Chapter 22, Section 1 of the Securities Market Act.

UK Aggregator Brands Gambling White Paper "Fair"

Thursday 27th April saw the UK Secretary for Culture, Media and Sport, Lucy Frazer, announce details of the Gambling White Paper at the House of Commons. The White Paper, which is the result of a long drawn-out Gambling Review that began in 2020, is said to be the biggest shake-up in gambling law to date.While much talk has surrounded the impact of proposals on operators and players, little has been said about the effect impending legislature changes will have on UK aggregators. With aggregators generating billions of pounds for the UK economy and creating thousands of jobs, their response

Hynion signs attractive land agreement for hydrogen refueling station in Jönköping

In July 2022, Hynion Sweden was granted a grant of SEK 61.4 million from the Swedish Energy Agency to build two more hydrogen refueling stations, one of which is in Jönköping. Now Hynion and Jönköping Municipality have signed a lease agreement for an area of land in the logistics area of Torsvik, south of Jönköping.Torsvik is Sweden's fastest growing logistics area with a strategic location on the E4, between the capitals of Scandinavia and close to the continent. Several major players, such as IKEA, Elgiganten, DHL and PostNord, have established warehouses here. Hynion's hydrogen refueling

BioStock: RSV drugs give hope to COPD patients

RSV infections can lead to serious conditions for patients with impaired lung capacity, such as COPD patients. Today there are no treatments for the virus, but that is soon about to change. BioStock takes a closer look at this respiratory illness and the drug candidates that are advancing towards market approval.Read the full article at biostock.se : https://www.biostock.se/en/2023/04/rsv-drugs-give-hope-to-copd-patients/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Changes in SCA's Group Management

Kristina Enander, President of SCA’s Pulp business area, will assume the role of Senior Vice President Strategic Development on May 1, 2023. In addition to overall responsibility for driving SCA's strategic development, the role also includes responsibility for research and development, the Group's technical department, and the Group's IT operations. Enander has worked at SCA since 1993. Mats Nordlander will assume the role of President, Pulp, on 1 May 2023. Nordlander will retain the role of President, Containerboard and will thus be responsible for SCA’s pulp and packaging paper

Idogen in discussions about a reversed merger. The company intends to add an agenda item at the annual general meeting on June 8 for possible liquidation

Idogen's work with capitalization has not yet produced the desired result. Idogen has initiated discussions with various stakeholders regarding reversed mergers. The board will call to the annual general meeting with a proposal for liquidation. The proposal for liquidation can be withdrawn if other solutions are in place before the meeting on June 8.   Idogen announced in a press release on April 3 that the company's cash will last until the end of June. In a press release on April 18, it was announced that work had begun to evaluate possibilities for a reversed merger for the company

Interim information January – March 2023

This interim report for the period January-March 2023 has been prepared for the purpose of complying with the terms of Corem Kelly AB’s (publ) bond and loan agreements. JANUARY–MARCH 2023 · Income amounted to SEK 918 million (844). · Profit from property management amounted to SEK 344 million (327). · Profit before tax amounted to SEK -868 million (1,797). EVENTS DURING THE FIRST QUARTER · In January, an agreement was signed with advertising agency R/GA in New York regarding approximately 1,600 sq.m. in the project 28&7, with move-in in January 2023. The agreement is

Notice of Annual General Meeting 2023

Notice is hereby served that the annual general meeting of Genetic Analysis AS (the "Company") will be held on Thursday 11 May 2023 at 15:00 hours in the Company's premises in Ulvenveien 80, Oslo.Shareholders are encouraged to submit a proxy with voting instructions prior to the general meeting, see Appendix 2. Shareholders that still wish to participate in the general meeting are encouraged to notify the Company as stipulated in Appendix 1. Agenda: 1. Opening of the meeting  2. Election of a chairperson and a person to co-sign the minutesThe board proposes that the chairman of

Alligo Interim Report 1 Jan–31 March 2023 - Profitable growth despite weaker market

First quarter highlights · Revenue increased by 9.2 per cent to MSEK 2,287 (2,095). Organic growth was 3.6 per cent. · Gross margin increased to 39.7 per cent (39.0). · Adjusted EBITA increased by 21 per cent to MSEK 127 (105), corresponding to an adjusted EBITA margin of 5.6 per cent (5.0). · Operating profit increased to MSEK 112 (80) and the operating margin amounted to 4.9 per cent (3.8). · Operating profit was charged with items affecting comparability of MSEK 0 (-9). · Profit from continuing operations amounted to MSEK 68 (56) and profit from discontinued

First Camp publish the 2022 annual report and sustainability report

Today, First Camp publishes its annual report and sustainability report for 2022.The documents are available here: www.corporate.firstcamp.se/en/for-investors/financial-reports/ and https://corporate.firstcamp.se/en/articles-of-association/sustainability-report/ . This information is information that United Camping AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 08.00 CET on April 28, 2022. For further information, please contact: Göran MeijerCFO

Terrafame’s net sales and operating result continued to grow in January−March 2023

The financial information presented about Terrafame Ltd in this release consists of unaudited FAS figures. The figures in brackets refer to the corresponding period of the previous year unless otherwise stated. January−March 2023 in brief: · Net sales from the battery chemicals business operations increased to EUR 66.2 (44.0) million, or around 38% of the company’s total net sales. · Net sales from the metal intermediates business operations totalled EUR 106.5 (83.0) million. · Total net sales were EUR 172.7 (127.0) million, representing an increase of 36% year-on-year. Net

Holmen invests to strengthen book paper and increase packaging paper production

To further strengthen Holmen’s market-leading position in book paper and increase production of Holmen's new packaging product, INNR, the company is investing SEK 450 million in rebuilding a paper machine at Braviken Paper Mill.Access to fossil-free electricity and local wood means that both Holmen’s paper mills are in a strong position that enables continued development of existing products. This will also create opportunities to grow in new segments in the packaging area. “In 2022, we launched a new corrugated board product, Holmen INNR, which has been well received by the market.

Redsense and the FDA held a Pre-Submission Meeting in Preparation for the 510(k) Premarket Submission for the Redsense Clamp

Redsense Medical announces that it held a 510(k) Pre-Submission meeting with the United States Food and Drug Administration (FDA) concerning the 510(k) Premarket submission for the Redsense Clamp. The aim of the meeting was to ensure that there is a common view of the regulatory pathway and documentation needed for the 510(k) Premarket application process. In the meeting, FDA officials provided constructive and supportive feedback and guidance concerning the regulatory requirements for the Redsense Clamp, which will be utilized in the coming 510(k) filing. “We are pleased with the

Letter from MindArk's CEO, Q2 2023

Dear valued shareholders, We know a lot of you want to get continuous updates about MindArk and Entropia Universe, and while we are publishing relevant press releases to the market, we at MindArk have decided that I will also release CEO updates to the market once per quarter. The ambition is to increase our communication with the market and keep all of you updated on the company's progress. Our main focus is always to keep developing Entropia Universe and use our resources accordingly, all to deliver value to our shareholders and users. As we are well into the second quarter of the

Kährs BondCo publishes annual report for 2022

Kährs BondCo AB (publ) announces that the company's annual report for 2022 in Swedish is now available on Kährs Group's website (kahrsgroup.com ) and is also attached to this press release.This information is information that Kährs BondCo AB (publ) is obliged to make public pursuant to the Swedish Securities Markets Act. The information was submitted for publication at 08:00 am CET on April 28, 2023.  For further information, please contact:Johan Magnusson, President and CEOPhone: +46 70 540 13 96 johan.magnusson@kahrs.com Andreas Larsson, CFO

Electrolux Group Q1 2023 Interim report

Highlights of the first quarter of 2023 · Net sales increased to SEK 32,734m (30,118), corresponding to an organic growth of 2.2%. Price remained solid, while weaker market demand resulted in lower volumes for the Group as a whole. New product ranges contributed to higher volumes and market share gains for the business areas North America and Latin America. · Operating income amounted to SEK -256m (1,575), corresponding to a margin of -0.8% (5.2). Operating income included non-recurring item of SEK -561m (656), that for the first quarter of 2023 related to the discontinuation of

poLight ASA: Last day of the Subscription Period in the Rights Issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to previous stock exchange announcements from poLight ASA ("poLight" or the "Company") regarding a fully underwritten rights issue of 12,918,660 new shares in the Company (the "Offer Shares"), raising gross proceeds of NOK 135 million (the "Rights Issue"). The

Hexagon Interim Report 1 January - 31 March 2023

• 8 per cent organic revenue growth (using fixed exchange rates and a comparable group structure)• Operating net sales increased by 11 per cent to 1,286.6 MEUR (1,163.4). Net sales including the reduction of acquired deferred revenue amounted to 1,285.1 MEUR (1,159.7)• Gross margin of 66.5 per cent (65.1)• Adjusted operating earnings (EBIT1) increased by 11 per cent to 371.2 MEUR (335.1)• Adjusted operating margin stable at 28.9 per cent (28.8)• Earnings before taxes, excluding adjustments, amounted to 344.4 MEUR (329.3)• Net earnings, excluding adjustments, amounted to 282.4

There are no items matching the current filter
There are no more items matching the current filter
Back to top